Skip to main content
. 2021 Oct 25;6:59. doi: 10.21037/tgh-20-314

Table 1. Time frame of disease recurrence/residual disease.

Follow-up period Number of patients with no residual disease at site of ablation Number of deaths Number of patients—loss to follow-up
1-month 15/17 (88%) 0 0
3-month 12/17 (71%) 3 0
6-month 11/17 (65%) 0 1
1-year 7/17 (41%) 1 2

Demonstrates time frame at which residual disease developed. Table also provides information regarding number of deaths and number of patients who were lost to follow-up at each time interval.